baber/WOPTO huggingface dataset:
Patent AU-2016383003-A1 (AU)
Title: Device and method for an effective invasive multi-segment neurostimulation
Inventor: TASS PETER ALEXANDER
IPC: A61N1/36
Filed: 2016-12-29
Abstract: The invention relates to a device for stimulating neurons, comprising the following - a stimulation unit which can be implanted into the body of a patient and which comprises a plurality of stimulation elements for stimulating neurons in a target areal of the brain and/or spinal cord of the patient with stimuli, and - a control unit which actuates the stimulation unit such that multiple groups of stimulation elements generate respective stimuli, wherein - each group comprises a plurality of stimulation elements of the stimulation unit, - at least two of the groups generate sequences of stimuli in a repetitive manner in a respective time pattern which consists of successive cycles, and - the sequences of stimuli generated by the at least two groups differ in terms of the number of cycles in which the sequence in which the stimulation elements generate the stimuli within one sequence is constant and/or in terms of the duration of the respective cycles.
Patent AU-2017200002-A1 (AU)
Title: Privacy Screen
Inventor: JOUBERT JACOBUS JOHANNES
IPC: A47G5/00
Filed: 2017-01-03
Abstract: -15 Abstract A privacy screen (10) comprising at least one pair of side rails (14a, 14b) and at least one connecting rail (16), the totality of the at least one connecting rail (14a, 14b) defining a first end (40) and a second end (42) each of the first end (40) and second end (42) being rotationally connected to one of the at least one pair of side rails (14a, 14b) and thereby define an interconnected length (L). A screen (18) is connected to the at least one pair of side rails (14a, 14b) and the at least one connecting rail (16) in a manner that allows the screen (18) to traverse along the interconnected length (L). Figure 7 $4
Patent AU-2017201821-A1 (AU)
Title: System and method for the rapid measurement of the visual contrast sensitivity function
Inventor: GREIVENKAMP JR
IPC: A61B3/024
Filed: 2017-03-17
Abstract: A computer, a high resolution monitor and a patient interface is utilized to implement a visual contrast sensitivity function measurement test. More specifically, a computerized video system is configured to implement a tilted-grating forced choice contrast sensitivity function test. The invention utilizes known measurement methods for the visual contrast sensitivity function and automates their use by computerizing the system and couples it with a patient-interactive user interface in order to produce an accurate quantitative result. MSION CONTRAST TEST SYSTEM 1 2 3 4 5 6 7 8 9 C .,, EL ,,H U A*N*K LEFT RC3HT LP BLANKI
Patent AU-2017204312-A1 (AU)
Title: Cytotoxic benzodiazepine derivatives
Inventor: LI WEI
IPC: C07D487/04
Filed: 2017-06-26
Abstract: 1: \rbr\Interwoven\NRPortbl\DCC\RBR\14943416_l docx-26 06/2017 The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepine compounds of formula (I)-(VII). The invention also provides conjugates of the benzodiazepine compounds linked to a cell binding agent. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.
Patent AU-2017204526-A1 (AU)
Title: Integration of physical and virtual lmr networks
Inventor: MCANDREW NIALL
IPC: H04W76/10
Filed: 2017-06-30
Abstract: Integration of a land mobile radio (LMR) communications system and other wireless IP based systems such as LTE by way of a virtual router and virtual base stations. The LMR 5 system may be either trunked or conventional. The virtual router maintains LMR IDs and also IP addresses for both physical and virtual base stations, multi bearer terminals and other components of the integrated system. Physical LMR base stations form a physical network. Virtual LMR base stations form a virtual network. These physical and virtual LMR networks communicate using ISSI, AIS or DFSI for example. Virtual Core0 12 IS - - Network System 40Physical P25 RFSS Controller (P25) T i Tr P25 Terminal . * 105 /r104 - ----- P25 Terminal (LTE) Hub \LTE P25 Terminal Terminal Multi-Bearfr Device10 Figure 1
Patent AU-2017208196-A1 (AU)
Title: Hydroelectric Installation
Inventor: HELBERG STEPHEN
IPC: F03B17/06
Filed: 2017-07-24
Abstract: HYDROELECTRIC INSTALLATION In one aspect there is disclosed a hydroelectric installation (80) comprising a turbine (12) for operative location within an aquatic environment. The turbine (12) comprises a first blade formation (14) and a second blade formation (16) disposed about a turbine hub (18). The turbine hub (18) extends longitudinally about a turbine hub axis. The hydroelectric installation further comprises a turbine support (22) for operative support of the turbine hub (18) within the aquatic environment. The turbine hub (18) is secured to the turbine support (22) so as to be pivotal about the turbine hub axis response to water flow across the first and second blade formations (14, 16). The first blade formation (14) is operatively adapted to be driven by water flow in a first direction and the second blade formation (16) is operatively adapted to be driven by water flow in a second opposite direction. The first blade formation (14) comprises a plurality of first blade formation segments (100), each first blade formation segment (100) comprising a section of the first blade formation (14) wherein the first blade formation segments are attached to each other to form the first blade formation (14). -222
Patent AU-2017213826-A1 (AU)
Title: Mutant smoothened and methods of using the same
Inventor: SHARPE HAYLEY
IPC: C07K14/705
Filed: 2017-02-02
Abstract: The emergence of mutations in tyrosine kinases following treatment of cancer patients with molecular-targeted therapy represents a major mechanism of acquired drug resistance. Here, mutations in the serpentine receptor, Smoothened (SMO) are described, which result in resistance to a Hedgehog (Hh) pathway inhibitor, such as in medulloblastoma. Amino acid substitutions in conserved residues of SMO maintain Hh signaling, but result in the inability of the Hh pathway inhibitor, GDC-0449, to suppress the pathway. In some embodiments, the disclosure provides for novel mutant SMO proteins and nucleic acids and for screening methods to detect SMO mutations and methods to screen for drugs that specifically modulate mutant SMO exhibiting drug resistance.
Patent AU-2017221132-A1 (AU)
Title: Fault current limiter and method thereof
Inventor: WILSON ADRIAN
IPC: G01R19/175
Filed: 2017-01-06
Abstract: A fault current limiter may include a current limiting leg to transmit a first current and a control leg in parallel with the current limiting leg, the control leg to transmit a second current. The control leg may include a plurality of solid state switches arranged in electrical series with one another; a plurality of current monitors arranged in electrical series with the plurality of solid state switches; and at least one triggering circuit, wherein the plurality of current monitors are electrically coupled to the at least one triggering circuit, and wherein the at least one triggering circuit is optically coupled to the plurality of solid state switches.
Patent AU-2017222470-A1 (AU)
Title: Tokenisation method and system for implementing exchanges on a blockchain
Inventor: WRIGHT CRAIG STEVEN
IPC: G06N7/00
Filed: 2017-02-14
Abstract: In accordance with the invention there may be provided a method and corresponding system for controlling the performance of a process conducted via a blockchain. The blockchain may or may not be the Bitcoin blockchain. The process may be a lending process. Advantageously, the invention provides a mechanism which enables the ultimate owner of a property or other asset to borrow funds against that asset, and sets out how this can be achieved in a manner which does not require the return to the investor(s) to be determined through the payment of interest. This makes it compliant with non-interest forms of lending. The invention provides a blockchain-implemented method (and corresponding system) of embedding data in a blockchain transaction (Tx). The method comprises the steps of deriving a public-key-private key cryptographic pair for the data; deriving a signature for the data using the public key-private key cryptographic pair; codifying the data to generate codified metadata for the data. The codified metadata is transmitted to the blockchain in a transaction. A signature is received and a script from at least one user to enable access to the embedded data. The script comprises a public key of a signatory. The metadata comprises a hash of the data and a pointer to the data so that it can be located. The hash is used as a primary key in a lookup table where the data is stored.
Patent AU-2017234275-A1 (AU)
Title: Protein a binding polypeptides, anti-EphA2 antibodies and methods of use thereof
Inventor: DRUMMOND DARYL
IPC: C07K16/46
Filed: 2017-03-13
Abstract: Provided by the present disclosure are antibodies (e.g., scFvs) that include CDRs and human framework regions that confer useful properties upon the antibodies. In certain embodiments, such properties include thermostability (e.g., increased melting temperature), efficient binding to
Patent AU-2017240129-A1 (AU)
Title: Methods for inhibiting angiogenesis in a subject in need thereof
Inventor: DEMOPULOS GREGORY A
IPC: C07K16/40
Filed: 2017-03-31
Abstract: In one aspect, the present invention provides methods for preventing, treating, reverting and/or delaying angiogenesis in a mammalian subject suffering from, or at risk for developing, an angiogenesis-dependent disease or condition, comprising administering to the subject an amount of a MASP-2 inhibitory agent effective to inhibit angiogenesis. In some embodiments of these aspects of the invention, the MASP-2 inhibitory agent is a MASP-2 antibody or fragment thereof.
Patent AU-2017248416-A1 (AU)
Title: Self-orienting syringe and syringe to-injector interface
Inventor: COWAN KEVIN P
IPC: A61M5/145
Filed: 2017-10-16
Abstract: A syringe comprising: a barrel having a distal end, a proximal end, and a sidewall extending substantially circumferentially between the distal end and the proximal end along a longitudinal axis; and at least one engagement member protruding from a terminal portion of the sidewall in a proximal direction along the longitudinal axis, the at least one engagement member tapering axially in a direction from the distal end toward the proximal end, wherein the at least one engagement member is configured for engagement with a locking mechanism of a fluid injector to releasably position the syringe with a syringe port of the fluid injector, and wherein a taper of the at least one engagement member is configured to rotationally guide the syringe into alignment with the locking mechanism and axially eject the syringe upon rotation of the syringe. 22 , -10 '-2 32 is39A B1 39A 39B -w20
Patent AU-2017250178-A1 (AU)
Title: Sequential loadings of multiple delivery vectors using a single selectable marker
Inventor: PERKINS EDWARD
IPC: C12N15/00
Filed: 2017-04-12
Abstract: The present invention provides a novel method for targeted integration of nucleic acids onto an autonomously replicating nucleic acid using site-directed recombination that allows for sequential loading of multiple delivery vectors using a single selectable marker.
Patent AU-2017251709-A1 (AU)
Title: Lighting and sensory system for a pulling tool
Inventor: FRETZ DARREN G
IPC: B66D1/60
Filed: 2017-10-24
Abstract: The present application relates generally to systems and methods for controlling operation of a winch system. As one example, lighting control system of the winch system may include a plurality of lights coupled to the winch, a plurality of sensors coupled to the winch, and a controller including memory with instructions for: adjusting an output of the plurality of lights in response to signals received from the plurality of sensors to indicate an operational status of the winch. In this way, the plurality of lights and plurality of sensors may work together in a synergistic manner to create alerts for an operator of the winch system. rcn c-- -N IILo co9 cU-
Patent AU-2017254983-A1 (AU)
Title: Systems and methods for ex-vivo organ care
Inventor: HASSANEIN WALEED
IPC: A01N1/02
Filed: 2017-11-06
Abstract: Abstract The invention provides, in various embodiments, systems, devices and methods relating to ex vivo organ care. In certain embodiments, the invention relates to maintaining an organ ex-vivo at near-physiologic conditions.
Patent AU-2017257306-A1 (AU)
Title: Method of forming multi-compartment tobacco pouch
Inventor: THESING ONESIO LUIS
IPC: B65D81/32
Filed: 2017-03-08
Abstract: Methods of forming a tobacco pouch having two or more compartments are disclosed. The methods include forming a multi-compartment tobacco pouch with a vertical form fill seal machine.
Patent AU-2017258912-A1 (AU)
Title: Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders
Inventor: EPSTEIN DAVID
IPC: C12N15/115
Filed: 2017-11-09
Abstract: Methods of treating complement-mediated ocular disorders by administering agents that inhibit a subject's complement component in an amount sufficient to treat the ocular disorder wherein, in a selected embodiment, said agent is an anti-complement aptamer that, in a preferred embodiment, is an anti-C5 aptamer.
Patent AU-2017265026-A1 (AU)
Title: Arginine - Free TNFR: Fc- Fusion Polypeptide Compositions And Methods Of Use
Inventor: MALONEY KEVIN
IPC: A61K47/02
Filed: 2017-11-21
Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.
Patent AU-2017272971-A1 (AU)
Title: Outer cap of medicinal fluid injection instrument
Inventor: RA YONG-KUK
IPC: A61M5/32
Filed: 2017-02-27
Abstract: The present invention relates to an outer cap of a medicinal fluid injection instrument and, specifically, to a device for reliably forming negative pressure at an injection channel when a medicinal fluid is suctioned and particularly, preventing the medicinal fluid from infiltrating an injection needle by reliably sealing the space between the inner circumferential surface of an outer cap and the circumferential surface of a medicinal fluid injection instrument since the outer cap, which temporarily forms a suction channel only during suctioning of the medicinal fluid but is removed so as to open the injection channel when the medicinal fluid is injected, is improved in the medicinal fluid injection instrument comprising a filter for filtering out foreign matter contained in the medicinal fluid. An outer cap (100) has a suction needle (110) suctioning a medicinal fluid and a cap hub (120) maintaining the sealing of the medicinal fluid injection instrument (200) so as to be coupled thereto, and has an inner space formed from the suction needle (110) to the cap hub (120), wherein an injection needle accommodating part (130) for accommodating the injection needle (210) according to the assembly of the medicinal fluid injection instrument (200) is formed in the inner space, and a sealing means for maintaining the sealing of a space between the inner space and the injection needle accommodating part (130) by coming into contact with the circumferential surface of the medicinal fluid injection instrument (200) according to the assembly of the medicinal fluid injection instrument (200) is provided at the entrance of the injection needle accommodating part (130), and thus the medicinal fluid injection instrument comprising a filter more reliably suctions the medicinal fluid and, particularly, the contamination of the injection needle caused by the medicinal fluid before filtration is fundamentally prevented, thereby enabling the marketability of the medicinal fluid injection instrument comprising a filter, and user safety to be maximized.
Patent AU-2017281507-A1 (AU)
Title: Operating method of a laundry washing machine and laundry washing machine implementing such method
Inventor: DEL POS MAURIZIO
IPC: D06F39/00
Filed: 2017-06-23
Abstract: Operating method of a laundry washing machine (1) comprising: an internal water softening device (13) which is crossed by the fresh water directed towards the washing tub (3) and/or the detergent dispenser (10), and which is filled with a water softening agent capable of reducing the hardness degree of the fresh water flowing through the same water softening device (13); a regeneration-agent container (21) containing a given amount of consumable salt or other regeneration agent; a first water-supply line (19) for selectively channelling a flow of fresh water into said regeneration-agent container (21) to form a brine capable of regenerating the water softening properties of said water softening agent; and a storage tank (35) which is fluidically connected to said regeneration-agent container (21) for receiving and accumulating the brine formed into said regeneration-agent container (21), and to said water softening device (13) for delivering said brine to the water softening device (13); the operating method of the laundry washing machine (1) comprising the steps of: channelling, via said first water-supply line (19), a given amount of fresh water into the regeneration-agent container (21) so as to form a given amount of brine that flows and accumulates into said storage tank (35); fluidically connecting the water softening device (13) in closed loop to said storage tank (35) bypassing said regeneration-agent container (21); circulating, for a given recirculation time period, said given amount of brine in closed loop through the water softening device (13) and the storage tank (35) while bypassing said regeneration-agent container (21); and lastly removing, after a given regeneration time period encompassing said recirculation time period, the brine from said water softening device (13).
Patent AU-2017320330-A1 (AU)
Title: Evaporator
Inventor: VUDRAG PETER JOSEPH
IPC: C02F1/10
Filed: 2017-08-01
Abstract: A process for separating distillate and waste from a water stream comprising: spraying the water stream together with compressed steam through one or more dual phase nozzles down into one or more vertical tubes contained in a shell and tube heat exchanger; evaporating water condensing the distillate; and ejecting the waste.
Patent AU-2017321791-A1 (AU)
Title: Substituted ureas and methods of making and using same
Inventor: TOUNGE BRETT A
IPC: C07C273/18
Filed: 2017-08-31
Abstract: The invention relates to substituted ureas, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.
Patent AU-2017324488-A1 (AU)
Title: Facility, method for storing and liquefying a liquefied gas and associated transport vehicle
Inventor: BERNHARDT JEAN-MARC
IPC: F17C5/04
Filed: 2017-07-19
Abstract: The invention primarily concerns a facility (1) for storing and cooling a liquefied gas, for example a liquefied natural gas, the facility comprising at least one tank (4) configured to contain the liquefied gas (2), a closed cooling circuit (10) configured to be supplied with liquefied gas (2) in the liquid state coming from the tank (4), at least one injection member (20) configured for re-injecting cooled liquefied gas (2) into the tank, the facility (1) being characterised in that it comprises at least one connection line (31) configured to recover a cooled gas (2) from at least one remote container (100) that is separate and independent from the facility.
Patent AU-2017336112-A1 (AU)
Title: Control device for power converter
Inventor: YASUMOTO RYUUJI
IPC: H02M7/48
Filed: 2017-08-24
Abstract: The present invention is a control device for a power converter with which a ripple component in direct-current voltage can be suppressed. The power converter converts a direct-current voltage (Vdc) containing a ripple component (Vdch) into an alternating-current voltage, and outputs the alternating-current voltage to a synchronous electric motor. The control device for the power converter is equipped with a ripple component detection unit (6) and a control circuit (3). The ripple component detection unit (6) detects the ripple component (Vdch). The control circuit (3) controls the power converter and increases the load angle of the synchronous electric motor in accordance with an increase in an instantaneous value of the ripple component (Vdch).
Patent AU-2017340229-A1 (AU)
Title: Coverage enhancement and normal modes switching related optimization
Inventor: BHATTAD KAPIL
IPC: H04B1/7156
Filed: 2017-08-08
Abstract: Coverage enhancements and coverage mode switching related optimizations are discussed for user equipments (UEs) that may switch between various coverage extension (CE) and non-CE modes of operation. In such enhancements, paging uncertainty and delays may be reduced by sending pages either simultaneously or using historical information over multiple coverage modes available to UEs. Random access procedures may be improved by providing CE mode random access procedures that are available when normal mode random access attempts fail and before declaring radio link failure. Additional aspects include improvements for more advanced UEs to improve coverage within normal mode operations by leveraging techniques used for narrowband CE mode operations, including transmission repetition and gapless transmission scheduling over hopped narrowband frequencies.
Patent AU-2017348348-A1 (AU)
Title: Genetically modified mouse model for human hepatocyte xenotransplantation
Inventor: SHULTZ LEONARD D
IPC: C12N15/113
Filed: 2017-10-27
Abstract: One or more embodiments of the present invention include an immunodeficient mouse genetically modified to include a gene encoding a PiZ variant (Glu342Lys) of human α-1 antitrypsin (AAT), wherein the mouse expresses the PiZ variant of human α-1 antitrypsin (Z-AAT), and has a reduced number of mouse hepatocytes compared to an immunodeficient mouse of the same type which does not express Z-AAT. The immunodeficient mouse genetically modified to include a gene encoding a PiZ variant of human AAT can be a genetically modified NSG, NRG or NOG mouse. The immunodeficient mouse may further include xenogeneic hepatocytes, such as human hepatocytes. Putative treatments of human liver disease can be assessed in mice provided according to aspects of the present disclosure.
Patent AU-2017349397-A1 (AU)
Title: Disposable diaper
Inventor: SAKAGUCHI SATORU
IPC: A61F13/56
Filed: 2017-09-29
Abstract: The present invention is provided with a side flap (14), a fastening tape (30) disposed on both side sections of the side flap (14) in the width direction, and a joining section (40) for joining a part of the fastening tape (30) to a non-skin-side of the side flap (14) in the thickness direction. In a deployed state, the magnitude of a force (F1S), for a case where the joining section (40) is peeled off when a region of the fastening tape (30) that is further outward in the width direction than the joining section (40) has been drawn in a direction oriented outward along the width direction, is greater than a minimum value of a force (F2S) for a case where the joining section (40) is peeled off when a region of the fastening tape (30) that is further inward in the width direction than the joining section (40) has been drawn in any direction between the direction oriented outward along the width direction and a direction oriented outward along the thickness direction.